X-ray equipment manufacturer Del Global Technologies has obtained final approval from the Securities and Exchange Commission regarding the settlement of claims against the company in connection with the restatement of financial statements filed by former
X-ray equipment manufacturer Del Global Technologies has obtained final approval from the Securities and Exchange Commission regarding the settlement of claims against the company in connection with the restatement of financial statements filed by former management for the fiscal years 1997 through the third quarter of fiscal 2000. The terms of the settlement are subject to approval by the U.S. District Court for the Southern District of New York. Del Global signed a consent decree with the SEC in December involving payment of a civil penalty of $400,000. The company is primarily engaged in the design, manufacture, and marketing of x-ray systems for the medical and dental markets, as well as high-voltage power conversion subsystems for medical and other industrial applications.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.